Risk, innovation and the regulation of health technologies: examining EU governance of blood and plasma products

References

• Abraham , J. and Reed , T. 2002 . Progress, innovation and regulatory science in drug development: the politics of international standard setting . Social studies of science , 32 ( 3 ) : 337 – 369 . doi: 10.1177/0306312702032003001
   PubMed Web of Science ®Google Scholar
• Beal , R. and van Aken , W. 1992 . Gift or good? A contemporary examination of the voluntary and commercial aspects of blood donation . Vox sanguinis , 63 ( 1 ) : 1 – 5 . doi: 10.1111/j.1423-0410.1992.tb01210.x
   Web of Science ®Google Scholar
• Beck , U. 1992 . Risk society: towards a new modernity , London : Sage .
   Google Scholar
• Borrás , S. , 2006 . Legitimate governance of risk at the EU level? The case of genetically modified organisms . Technological forecasting and social change , 73 ( 1 ), 61 – 75 . doi: 10.1016/j.techfore.2005.06.011
   Web of Science ®Google Scholar
• Brownsword , R. 2008a . “ So what does the world need now? Reflections on regulating technologies ” . In Regulating technologies: legal futures, regulatory frames and technological fixes , Edited by: Brownsword , R. and Yeung , K. 23 – 48 . Oxford : Hart .
   Google Scholar
• Brownsword , R. 2008b . Risks, rights and the technological revolution , Oxford : Oxford University Press .
   Google Scholar
• Burnouf , T. 2007 . Modern plasma fractionation . Transfusion medicine reviews , 21 ( 2 ) : 101 – 117 . doi: 10.1016/j.tmrv.2006.11.001
   PubMed Web of Science ®Google Scholar
• Commission Directive 2003/63/EC of 25 June 2003 amending Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use . OJ L 159 .
   Google Scholar
• Commission Directive 2005/61/EC having regard to Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC . OJ L 256 .
   Google Scholar
• Commission Directive 2005/62/EC of 30 September 2005 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards Community standards and specifications relating to a quality system for blood establishments . OJ L 256 .
   Google Scholar
• Commission of the European Communities , 1994 . Commission communication on blood safety and self-sufficiency in the Community . COM (94) 652 final .
   Google Scholar
• Commission of the European Communities , 2000 . Communication from the Commission on the precautionary principle . COM (2000) 1 .
   Google Scholar
• Commission of the European Communities , 2001 . European governance: a White Paper . COM (2001) 428 final .
   Google Scholar
• Commission of the European Communities , 2002 . Innovation tomorrow, innovation policy and the regulatory framework: making innovation an integral part of the broader structural agenda . Prepared by Louis Lengrand & Associés, PREST (University of Manchester) and ANRT (France). Innovation paper no. 28. Directorate-General for Enterprise . Luxembourg : Office for Official Publications of the European Communities .
   Google Scholar
• Commission of the European Communities , 2006a . Communication from the Commission to the Council, the European Parliament, the European Economic and Social Committee and the Committee of the Regions: putting knowledge into practice: a broad-based innovation strategy for the EU . COM (2006) 502 final .
   Google Scholar
• Commission of the European Communities , 2006b . Report from the Commission to the Council and the European Parliament on the promotion by Member States of voluntary, unpaid blood donations . COM (2006) 217 final .
   Google Scholar
• Committee for Proprietary Medicinal Products , 2004 . Guideline on the scientific data requirements for a plasma master file (PMF) . European Agency for the Evaluation of Medicinal Products EMEA/CPMP/BWP/3704/03 , 26 February .
   Google Scholar
• Corkin , J. , 2008 . Science, legitimacy and the law: regulating risk regulation judiciously in the European Community . European law review , 33 ( 3 ), 359 – 384 .
   Web of Science ®Google Scholar
• Council Directive 89/381/EEC of 14 June 1989 extending the scope of Directives 65/65/EEC and 75/319/EEC on the approximation of provisions laid down by law, regulation or administrative action relating to medicinal products and laying down special provisions for proprietary medicinal products derived from human blood or human plasma (repealed) .
   Google Scholar
• Council Recommendation 98/463/EC of 29 June 1998 on the suitability of blood and plasma donors and the screening of donated blood in the European Community . OJ C 203 .
   Google Scholar
• de Búrca , G. and Scott , J. 2006 . “ Introduction: new governance, law and constitutionalism ” . In Law and new governance in the EU and the US , Edited by: de Búrca , G. 1 – 14 . Oxford : Hart .
   Google Scholar
• del Pozo , P.R. 1994 . Paying donors and the ethics of blood supply . Journal of medical ethics , 20 ( 1 ) : 31 – 35 . doi: 10.1136/jme.20.1.31
   Web of Science ®Google Scholar
• Directive 2001/83 of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use . OJ L 311 .
   Google Scholar
• Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC . OJ L 33 .
   Google Scholar
• European Commission , 2010a . Communication from the Commission to the Council, European Parliament, the Economic and Social Committee and the Committee of the Regions on the application of Directive 2002/98/EC settings standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC . COM (2010) 3 final .
   Google Scholar
• European Commission , 2010b . Meeting of the Competent Authorities on blood and blood components (Art. 25 Dir. 2002/98/EC) , 12–13 April 2010 , SANCO C6 TB/RP D(2010) 360180 Brussels .
   Google Scholar
• European Commission , 2010c . Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions. Smart Regulation in the European Union . COM (2010) 543 final .
   Google Scholar
• European Commission , 2010d . Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions. Europe 2020 Flagship Initiative Innovation Union . COM (2010) 546 final .
   Google Scholar
• European Commission , 2011 . Report from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions. 2nd Report on voluntary and unpaid donation of blood and blood components . COM (2011) 138 final .
   Google Scholar
• European Medicines Agency , n.d . European Public Assessment Reports . Available from: www.ema.europa.eu
   Google Scholar
• European Opinion Research Group (EEIG) , 2003 . Le don de sang . Eurobaromètre special 1883-4/Vague 58.2. Report prepared for the European Commission .
   Google Scholar
• Faber , J.-C. 2004 . The European Blood Directive: a new era of blood regulation has begun . Transfusion medicine , 14 ( 4 ) : 257 – 273 . doi: 10.1111/j.0958-7578.2004.00513.x
   Web of Science ®Google Scholar
• Farrell , A.M. 2005 . “ Emerging EU governance in public health: the case of blood policy and regulation ” . In Health governance in Europe , Edited by: Steffen , M. 134 – 151 . London : Routledge .
   Google Scholar
• Farrell , A.M. 2006 . Is the gift still good? The politics and regulation of blood safety in the European Union . Medical law review , 14 ( 2 ) : 155 – 179 . doi: 10.1093/medlaw/fwl001
   Google Scholar
• Farrell , A.M. 2009 . The politics of risk and EU governance of human material . Maastricht journal of European and comparative law , 16 ( 1 ) : 41 – 64 .
   Google Scholar
• Farrell , A.M. 2012 . The politics of blood: ethics innovation and the regulation of risk , Cambridge : Cambridge University Press .
   Google Scholar
• Farrell , A.M. 2013 . “ Risk, legitimacy and EU regulation of health technologies ” . In European law and new health technologies , Edited by: Flear , M.L. , Farrell , A.M. , Hervey , T.K. and Murphy , T. Oxford : Oxford University Press . (in press)
   Google Scholar
• Faulkner , A. 2009 . Medical technology into healthcare and society: a sociology of devices, innovation and governance , Basingstoke : Palgrave Macmillan .
   Google Scholar
• Fisher , E. 2007 . Risk regulation and administrative constitutionalism , Oxford : Hart .
   Google Scholar
• Gonçalves , M.E. 2006 . Risk and the governance of innovation in Europe: an introduction . Technological forecasting and social change , 73 ( 1 ) : 1 – 12 . doi: 10.1016/j.techfore.2005.06.008
   Web of Science ®Google Scholar
• Hood , C. , Rothstein , H. and Baldwin , R. 2001 . The government of risk: understanding risk regulation regimes , Oxford : Oxford University Press .
   Google Scholar
• INRA (Europe) , 1995 . Europeans and blood . Eurobarometer 41.0, Report prepared for the European Commission .
   Google Scholar
• Jasanoff , S. 2002 . Citizens at risk: cultures of modernity in the US and EU . Science as culture , 11 ( 3 ) : 363 – 380 . doi: 10.1080/0950543022000005087
   Google Scholar
• Jasanoff , S. 2005 . Designs on nature: science and democracy in Europe and the United States , Princeton , NJ : Princeton University Press .
   Google Scholar
• Kent , J. , et al. , 2006 . Towards governance of tissue engineered technologies in Europe: framing the case for a new regulatory regime . Technological forecasting and social change , 73 ( 1 ), 41 – 60 . doi: 10.1016/j.techfore.2005.06.006
   Web of Science ®Google Scholar
• Keown , J. 1997 . The gift of blood in Europe: an ethical defence of EC Directive 89/381 . Journal of medical ethics , 23 ( 2 ) : 96 – 100 . doi: 10.1136/jme.23.2.96
   Web of Science ®Google Scholar
• Kritikos , M. 2009 . Traditional risk analysis and releases of GMOs into the European Union: space for non-scientific factors? . European law review , 34 ( 3 ) : 405 – 432 .
   Web of Science ®Google Scholar
• Kroner , B.K. 1994 . HIV-1 infection incidence among persons with hemophilia in the United States and Europe . Journal of the acquired immune deficiencies syndrome , 7 ( 3 ) : 279 – 286 .
   PubMed Web of Science ®Google Scholar
• Leveton , L. , Sox , H.C. and Stoto , M.A. 1995 . HIV and the blood supply: an analysis of crisis decisionmaking (Committee to Study HIV Transmission through Blood and Blood Products, Division of Health Promotion and Disease Prevention) , Washington , DC : National Academy Press .
   Google Scholar
• Lewis , S. 1993 . EC Commission and blood self-sufficiency . The Lancet , 342 : 1228 doi: 10.1016/0140-6736(93)92199-4
   Web of Science ®Google Scholar
• Lundvall , B.-A. 1992 . National systems of innovation: towards a theory of innovation and interactive learning . London : Pinter .
   Google Scholar
• Magnette , P. 2003 . European governance and civic participation: beyond elitist citizenship? . Political studies , 51 ( 1 ) : 144 – 160 . doi: 10.1111/1467-9248.00417
   Web of Science ®Google Scholar
• Majone , G. 1996 . Regulating Europe . London : Routledge .
   Google Scholar
• Nelson , R.R. 1993 . National innovation systems: a comparative analysis . Oxford : Oxford University Press .
   Google Scholar
• Rabinow , P. 1999 . French DNA – trouble in purgatory , Chicago , IL : Chicago University Press .
   Google Scholar
• Renn , O. 1998 . Three decades of risk research: accomplishments and new challenges . Journal of risk research , 1 ( 1 ) : 49 – 71 . doi: 10.1080/136698798377321
   Google Scholar
• Robinson , E. , 2007 . The European Union Blood Safety Directive and its implications for blood services . Vox sanguinis , 93 ( 2 ), 122 – 130 . doi: 10.1111/j.1423-0410.2007.00942.x
   Web of Science ®Google Scholar
• Silvester , G. 2006 . Regulatory overview – stable products background, current state of the art and future challenges . Pharmaceuticals policy and law , 7 : 151 – 69 .
   Google Scholar
• Skelcher , C. and Torfing , J. 2010 . Improving democratic governance through institutional design: civic participation and democratic ownership in Europe . Regulation and governance , 4 ( 1 ) : 71 – 91 .
   Web of Science ®Google Scholar
• Smith , M.J. 2004 . Mad cows and mad money: problems of risk in the marking and understanding of policy . British journal of politics and international relations , 6 ( 3 ) : 312 – 332 . doi: 10.1111/j.1467-856X.2004.00142.x
   Google Scholar
• Smits , R. 2002 . Innovation studies in the 21st century: questions from a user's perspective . Technological forecasting and social change , 69 ( 2 ) : 861 – 883 . doi: 10.1016/S0040-1625(01)00181-0
   Web of Science ®Google Scholar
• Starr , D. 1998 . Blood: an epic history of medicine and commerce , New York : Alfred A. Knopf .
   Google Scholar
• Titmuss , R.M. 1970 . The gift relationship: from human blood to social policy , London : George Allen and Unwin .
   Google Scholar
• Valverde , J.L. 2006 . The political dimension of blood and plasma derivatives . Pharmaceuticals policy and law , 7 : 21 – 33 .
   Google Scholar
• van Asselt , M. and Vos , E. 2006 . The precautionary principle and the uncertainty paradox . Journal of risk research , 9 ( 4 ) : 313 – 336 . doi: 10.1080/13669870500175063
   Web of Science ®Google Scholar
• von Hoegen , I. and Gustafson , M. 2006 . The importance of greater regulatory harmonization . Pharmaceuticals policy and law , 7 : 171 – 176 .
   Google Scholar
• von Schubert , H. 1994 . Donated blood – gift or commodity? Some economic and ethical considerations on voluntary vs commercial donation of blood . Social science and medicine , 39 ( 2 ) : 201 – 206 . doi: 10.1016/0277-9536(94)90328-X
   PubMed Web of Science ®Google Scholar
• Waldby , C. and Mitchell , R. 2006 . Tissue economies: blood, organs and cell lines in late capitalism , Durham , NC : Duke University Press .
   Google Scholar
• Webster , A. 2007 . Health, technology and society: a critique , Basingstoke : Palgrave Macmillan .
   Google Scholar
• Weimer , M. 2010 . Applying precaution in EU authorization of genetically modified products – challenges and suggestions for reform . European law journal , 16 ( 5 ) : 624 – 657 . doi: 10.1111/j.1468-0386.2010.00526.x
   Web of Science ®Google Scholar
• World Health Organization , n.d . Essential health technologies . Available from: http://www.who.int/eht/en [Accessed 22 August 2012] .
   Google Scholar
• Wynne , B. 2001 . Creating public alienation: expert cultures of risk and ethics on GMOs . Science as culture , 10 ( 4 ) : 445 – 481 . doi: 10.1080/09505430120093586
   PubMedGoogle Scholar